H2020 RESEARCH & INNOVATION

Pregled otvorenih natječaja H2020 za Znanost i inovacije

Naslovna > Znanost > Novosti > H2020 RESEARCH & INNOVATION > H2020 RESEARCH & INNOVATION

CALL: H2020-JTI-IMI2-2017-13-TWO-STAGE
Call identifier: H2020-JTI-IMI2-2017-13-TWO-STAGE (natječaj u dvije faze)
Datum objave natječaja: 30. studenog 2017.
Rok za prijavu: 28. veljače 2018.
Rok za prijavu - faza II: 6. rujna 2018.

Teme:
IMI2-RIA Research and Innovation action:

IMI2-2017-13-01	Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches
IMI2-2017-13-02	Genome-Environment Interactions in Inflammatory Skin Disease
IMI2-2017-13-03	The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
IMI2-2017-13-04	Mitochondrial Dysfunction in Neurodegeneration
IMI2-2017-13-06	A sustainable European induced pluripotent stem cell platform
IMI2-2017-13-07	Linking digital assessment of mobility to clinical endpoints to support regulatory acceptance and clinical practice
IMI2-2017-13-08	Human Tumour Microenvironment Immunoprofiling
IMI2-2017-13-09	ConcePTION – Continuum of Evidence from Pregnancy Exposures, Reproductive Toxicology and Breastfeeding to Improve Outcomes Now
IMI2-2017-13-10	Improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system
IMI2-2017-13-11	Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
IMI2-2017-13-12	Pilot programme on a Clinical Compound Bank for Repurposing: Cardiovascular diseases and diabetes
IMI2-2017-13-13	Pilot programme on a Clinical Compound Bank for Repurposing: Respiratory diseases
IMI2-2017-13-14	Pilot programme on a Clinical Compound Bank for Repurposing: Neurodegenerative diseases
IMI2-2017-13-15	Pilot programme on a Clinical Compound Bank for Repurposing: Rare/orphan diseases

IMI2-CSA Coordination & support action:

IMI2-2017-13-05

Support and coordination action for the projects of the Neurodegeneration area of the Innovative Medicines Initiative

Izvor: European Commission

Ispiši stranicu